WHX LAGOS 2025, Africa's most influential healthcare innovation expo, opens grandly at the Lagos International Convention Center in Nigeria on June 2nd! BIOELAB meets the appointment of innovation, dialogue with global partners!
The 12th West Africa Nigeria International Medical Device Show is one of the most influential events in the medical industry in West Africa, aiming to showcase the latest medical equipment, technologies and services and promote international medical cooperation and exchange.
The show attracts medical equipment manufacturers, pharmaceutical suppliers, medical institutions and professionals from around the world to discuss the latest trends and directions in the medical industry.
Arriving in West Africa for the first time, BIOELAB showcased its "full range of innovative" in vitro diagnostic products, demonstrating its independent research and development capabilities in the field of in vitro diagnostics through four areas: chemiluminescence, biochemistry, coagulation, and blood cells.
Looking forward to exchanging with IVD companies around the world through better products and services, with the goal of promoting innovation and upgrading, and striving forward on the path to high-quality development.
During the exhibition, BIOELAB attracted a number of international clients, including core groups such as hospitals and laboratories. Many visiting experts and scholars reached initial collaboration intentions, demonstrating global recognition of BIOELAB's technological strength.
In the face of a volatile market environment, in recent years, BIOELAB has focused on its core R&D strength, deeply integrated clinical needs, and formed a multi-scenario IVD solution covering primary care to high-throughput laboratories.
Over the years, BIOELAB has repeatedly "gone global" to break through, with IVD products sold in more than 80 countries around the world, with more than 60,000 units installed, continuously providing efficient and reliable technical support for global precision diagnosis and treatment.
